Cystic Kidney and Liver Diseases Panel
New York
Approved
Genes
Conditions
- Nephronophthisis
- Autosomal Dominant Polycystic Kidney Disease
- Autosomal Recessive Polycystic Kidney Disease
- Medullary Cystic Kidney Disease
- Polycystic Liver Disease
- Joubert Syndrome
- Tuberous Sclerosis Complex (TSC)
- Von Hippel-Lindau syndrome
- Polycystic Kidney Disease
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Development of appropriate evaluation and management plan
- Evaluation of family members as possible donors for kidney/liver transplantation
- Testing of at-risk relatives for specific known variant(s) previously identified in an affected family member
- Prenatal diagnosis for known familial pathogenic variant(s) in at-risk pregnancies
- Genetic counseling, especially recurrence risk and prenatal diagnosis
Lab Method
- Next-Gen Sequencing
- Deletion/Duplication Analysis
Important Information
Test Code
TG23
CPT Codes*
81406x2; 81407x1; 81408x2
ABN Required
No
Turnaround Time**
4-6 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.
Test Documents
Billing
Targeted Variant Testing